BioMarin Pharmaceutical Cash on Hand 2006-2019 | BMRN

BioMarin Pharmaceutical cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • BioMarin Pharmaceutical cash on hand for the quarter ending September 30, 2019 was $0.721B, a 50.06% decline year-over-year.
  • BioMarin Pharmaceutical cash on hand for 2018 was $1.084B, a 22.33% decline from 2017.
  • BioMarin Pharmaceutical cash on hand for 2017 was $1.396B, a 76.78% increase from 2016.
  • BioMarin Pharmaceutical cash on hand for 2016 was $0.79B, a 33.25% increase from 2015.
BioMarin Pharmaceutical Annual Cash on Hand
(Millions of US $)
2018 $1,084
2017 $1,396
2016 $790
2015 $593
2014 $945
2013 $785
2012 $448
2011 $195
2010 $274
2009 $301
2008 $560
2007 $586
2006 $289
2005 $48
BioMarin Pharmaceutical Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $721
Q2 2019 $731
Q1 2019 $895
Q4 2018 $1,084
Q3 2018 $1,443
Q2 2018 $1,363
Q1 2018 $1,383
Q4 2017 $1,396
Q3 2017 $1,257
Q2 2017 $728
Q1 2017 $678
Q4 2016 $790
Q3 2016 $1,035
Q2 2016 $503
Q1 2016 $457
Q4 2015 $593
Q3 2015 $618
Q2 2015 $682
Q1 2015 $1,009
Q4 2014 $945
Q3 2014 $666
Q2 2014 $837
Q1 2014 $887
Q4 2013 $785
Q3 2013 $380
Q2 2013 $401
Q1 2013 $402
Q4 2012 $448
Q3 2012 $426
Q2 2012 $403
Q1 2012 $233
Q4 2011 $195
Q3 2011 $224
Q2 2011 $259
Q1 2011 $253
Q4 2010 $274
Q3 2010 $352
Q2 2010 $338
Q1 2010 $324
Q4 2009 $301
Q3 2009 $363
Q2 2009 $346
Q1 2009 $552
Q4 2008 $560
Q3 2008 $563
Q2 2008 $576
Q1 2008 $575
Q4 2007 $586
Q3 2007 $587
Q2 2007 $588
Q1 2007 $273
Q4 2006 $289
Q3 2006 $294
Q2 2006 $306
Q1 2006 $348
Q4 2005 $48
Q3 2005 $66
Q2 2005 $27
Q1 2005 $43
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.105B $1.491B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.020B 14.98
CSL (CSLLY) Australia $101.716B 0.00
Gilead Sciences (GILD) United States $84.765B 10.91
Vertex Pharmaceuticals (VRTX) United States $63.547B 57.67
Biogen (BIIB) United States $58.597B 10.01
Illumina (ILMN) United States $44.168B 45.66
Regeneron Pharmaceuticals (REGN) United States $43.913B 18.60
Alexion Pharmaceuticals (ALXN) United States $22.702B 10.56
Seattle Genetics (SGEN) United States $20.383B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.943B 38.50
Genmab (GNMSF) Denmark $15.176B 48.81
Alnylam Pharmaceuticals (ALNY) United States $14.987B 0.00
Galapagos (GLPG) Belgium $14.255B 36.73
Exact Sciences (EXAS) United States $13.326B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.443B 0.00
Sarepta Therapeutics (SRPT) United States $9.176B 0.00
QIAGEN (QGEN) Netherlands $8.414B 25.91
Guardant Health (GH) United States $8.209B 0.00
Bio-Techne Corp (TECH) United States $8.011B 54.82
BioNTech SE (BNTX) Germany $7.326B 0.00
Ascendis Pharma (ASND) Denmark $6.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.905B 0.00
Reata Pharmaceuticals (RETA) United States $6.773B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.750B 17.16
Exelixis (EXEL) United States $6.527B 18.36
Amarin (AMRN) Ireland $6.383B 0.00
Moderna (MRNA) United States $6.239B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.142B 0.00
Repligen (RGEN) United States $5.264B 96.31
Acceleron Pharma (XLRN) United States $5.035B 0.00
China Biologic Products (CBPO) China $4.598B 25.90
Bluebird Bio (BLUE) United States $4.584B 0.00
Adaptive Biotechnologies (ADPT) United States $4.203B 0.00
MorphoSys AG (MOR) Germany $3.896B 0.00
Mirati Therapeutics (MRTX) United States $3.706B 0.00
Blueprint Medicines (BPMC) United States $3.672B 0.00
Zai Lab (ZLAB) China $3.650B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
Immunomedics (IMMU) United States $3.486B 0.00
NeoGenomics (NEO) United States $3.456B 183.89
CRISPR Therapeutics AG (CRSP) Switzerland $3.454B 58.51
Momenta Pharmaceuticals (MNTA) United States $3.363B 0.00
Emergent Biosolutions (EBS) United States $3.334B 23.31
Alkermes (ALKS) Ireland $3.224B 255.38
Genmab (GMAB) Denmark $3.220B 12.63
Halozyme Therapeutics (HALO) United States $3.149B 0.00
MyoKardia (MYOK) United States $3.142B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.074B 0.00
UniQure (QURE) Netherlands $2.774B 0.00
Amicus Therapeutics (FOLD) United States $2.760B 0.00
Insmed (INSM) United States $2.719B 0.00
Arena Pharmaceuticals (ARNA) United States $2.667B 6.20
Denali Therapeutics (DNLI) United States $2.379B 0.00
Epizyme (EPZM) United States $2.321B 0.00
Principia Biopharma (PRNB) United States $2.290B 0.00
Fate Therapeutics (FATE) United States $2.219B 0.00
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Alector (ALEC) United States $2.059B 0.00
REGENXBIO (RGNX) United States $1.977B 0.00
Zymeworks (ZYME) Canada $1.829B 0.00
Ligand Pharmaceuticals (LGND) United States $1.780B 51.97
Akcea Therapeutics (AKCA) United States $1.732B 0.00
Arvinas (ARVN) United States $1.711B 0.00
Coherus BioSciences (CHRS) United States $1.578B 0.00
Myriad Genetics (MYGN) United States $1.483B 26.17
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Zealand Pharma (ZEAL) Denmark $1.474B 0.00
Zealand Pharma (ZLDPF) Denmark $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Intra-Cellular Therapies (ITCI) United States $1.361B 0.00
Editas Medicine (EDIT) United States $1.349B 0.00
Revance Therapeutics (RVNC) United States $1.244B 0.00
Athenex (ATNX) United States $1.193B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.187B 0.00
Twist Bioscience (TWST) United States $1.174B 0.00
PHARMA MAR SA (PHMMF) Spain $1.029B 0.00
Adverum Biotechnologies (ADVM) United States $1.017B 0.00
Mesoblast (MESO) Australia $0.931B 0.00
Cytokineticsorporated (CYTK) United States $0.915B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.874B 0.00
DBV Technologies S.A (DBVT) France $0.874B 0.00
Vericel (VCEL) United States $0.851B 317.17
Codexis (CDXS) United States $0.823B 0.00
Heska (HSKA) United States $0.805B 205.60
Cellectis S.A (CLLS) France $0.797B 0.00
Intrexon (PGEN) United States $0.768B 0.00
Retrophin (RTRX) United States $0.738B 0.00
ANI Pharmaceuticals (ANIP) United States $0.736B 12.56
Arcus Biosciences (RCUS) United States $0.731B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.716B 6.02
Cara Therapeutics (CARA) United States $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.688B 0.00
GENFIT S.A (GNFT) France $0.677B 0.00
Kadmon Holdings (KDMN) United States $0.655B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.632B 0.00
Cel-Sci (CVM) United States $0.620B 0.00
Bellus Health (BLU) Canada $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.599B 20.49
Clovis Oncology (CLVS) United States $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.590B 0.00
NantKwest (NK) United States $0.586B 0.00
AC Immune SA (ACIU) Switzerland $0.568B 13.13
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.544B 0.00
Compugen (CGEN) Israel $0.539B 0.00
Agenus (AGEN) United States $0.521B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.473B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
Sorrento Therapeutics (SRNE) United States $0.445B 0.00
Mersana Therapeutics (MRSN) United States $0.444B 0.00
AnaptysBio (ANAB) United States $0.435B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.432B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.423B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.414B 0.00
Dynavax Technologies (DVAX) United States $0.412B 0.00
Precision BioSciences (DTIL) United States $0.409B 0.00
Avid Bioservices (CDMO) United States $0.407B 0.00
Pfenex (PFNX) United States $0.407B 0.00
PDL BioPharma (PDLI) United States $0.396B 9.91
Gritstone Oncology (GRTS) United States $0.372B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Inovio Pharmaceuticals (INO) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.356B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 0.00
WAVE Life Sciences (WVE) Singapore $0.333B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
OSMOTICA PHARM (OSMT) United States $0.313B 0.00
MannKind (MNKD) United States $0.312B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Syros Pharmaceuticals (SYRS) United States $0.311B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
Starpharma Holdings (SPHRY) Australia $0.302B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.297B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.276B 0.00
Kamada (KMDA) Israel $0.274B 11.39
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
VBI Vaccines (VBIV) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
IVERIC Bio (ISEE) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
Geron (GERN) United States $0.256B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.251B 0.00
Protagonist Therapeutics (PTGX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Kala Pharmaceuticals (KALA) United States $0.240B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Prometic Life Sciences (LMNL) Canada $0.228B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.225B 0.00
Alcobra (ARCT) United States $0.223B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.223B 11.46
Pieris Pharmaceuticals (PIRS) United States $0.216B 0.00
Arbutus Biopharma (ABUS) Canada $0.212B 0.00
Cerecor (CERC) United States $0.211B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.211B 0.00
Affimed (AFMD) Germany $0.209B 0.00
Theratechnologies (THTX) Canada $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
VolitionRX (VNRX) Singapore $0.205B 0.00
TELA Bio (TELA) United States $0.200B 0.00
Athersys (ATHX) United States $0.199B 0.00
Five Prime Therapeutics (FPRX) United States $0.195B 0.00
Fortress Biotech (FBIO) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 4.99
Spero Therapeutics (SPRO) United States $0.184B 0.00
Exicure (XCUR) United States $0.183B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Northwest Biotherapeutics (NWBO) United States $0.166B 0.00
CorMedix Inc (CRMD) United States $0.166B 0.00
Selecta Biosciences (SELB) United States $0.161B 0.00
Aptinyx (APTX) United States $0.160B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Verastem (VSTM) United States $0.156B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
ARAVIVE, INC (ARAV) United States $0.143B 0.00
Palatin Technologies (PTN) United States $0.141B 3.85
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
OvaScience (MLND) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Prima BioMed (IMMP) Australia $0.105B 0.00
Applied Genetic Technologies (AGTC) United States $0.104B 0.00
Proteostasis Therapeutics (PTI) United States $0.101B 0.00
Happiness Biotech Group (HAPP) China $0.100B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Emmaus Life Sciences (EMMA) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Synlogic (SYBX) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.084B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 5.05
Acorda Therapeutics (ACOR) United States $0.075B 0.00
Trevena (TRVN) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Celsion (CLSN) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
IBio (IBIO) United States $0.026B 0.00
VIVUS (VVUS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00